Kaplan-Meier curves of (A) progression-free survival and (B) overall survival. gan Lu Xie (20428615)

Pynciau:

Supplementary Figure S1 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001 gan Yan Zhou (15053225)

Pynciau:

Supplementary Table 1 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants gan Dhruv Chachad (14954640)

Pynciau:

Supplementary Table 4 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants gan Dhruv Chachad (14954640)

Pynciau:

Supplementary Table 5 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants gan Dhruv Chachad (14954640)

Pynciau:

Supplementary Table 3 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants gan Dhruv Chachad (14954640)

Pynciau:

Supplementary Table 2 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants gan Dhruv Chachad (14954640)

Pynciau: